Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC 18:1_19:2)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003694 AN006060 FOLFIRINOX effects on lipidomics in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST003664 AN006020 Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function. T-cells Mouse Cancer University of Chicago LC-MS
ST003637 AN005974 lomitapide effects on lipidomics Pancreas Human Cancer Pennsylvania State University LC-MS
ST003328 AN005452 Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular lipidomics Stem cells Human Multiple sclerosis University of Colorado Denver LC-MS
ST003328 AN005453 Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular lipidomics Stem cells Human Multiple sclerosis University of Colorado Denver LC-MS
ST003222 AN005283 A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 Heart Mouse Ischemia University of Mississippi Medical Center LC-MS
ST003130 AN005133 Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal blood Blood Mouse University of Copenhagen LC-MS
  logo